Hemopoietic growth factors

From Wikipedia, the free encyclopedia

You have new messages (last change).
There are very few or no other articles that link to this one.
Please help introduce links in articles on related topics. After links have been created, remove this message.
This article has been tagged since September 2006.

Hemopoietic growth factors regulate the differentiation and proliferation of particular progenitor cells. Made available through recombinant DNA technology, they hold tremendous potential for medical uses when a person's natural ability to form blood cells is diminished or defective. Recombinant erythropoietin (EPO) is very effective in treating the diminished red blood cell production that accompanies end-stage kidney disease.

Granulocyte-macrophage colony-stimulating factor and granulovyte CSF are given to stimulate white blood cell formation in cancer patients who are receiving chemotherapy, which tends to kill their red bone marrow cells as well as the cancer cells. Thrombopoietin shows great promise for preventing platelet depletion during chemotherapy. CSFs and thrombopoietin also improve the outcome of patients who receive bone marrow transplants.


This medical article is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../h/e/m/Hemopoietic_growth_factors.html"